Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-11-08
1993-11-16
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514305, 514315, 514326, 514340, 546124, 546125, 546133, 546209, 546246, 546275, 546277, 546334, C07D41304, A61K 3141
Patent
active
052624277
ABSTRACT:
Azacyclic compounds selected from the group consisting of ##STR1## wherein R.sup.1 is H or C.sub.1-6 -alkyl
REFERENCES:
patent: 3265692 (1966-08-01), Harsanyi et al.
patent: 4144343 (1979-03-01), Baldwin et al.
patent: 4518601 (1985-05-01), Kristiansen et al.
patent: 4710508 (1987-12-01), Bergmeier et al.
patent: 4786648 (1988-11-01), Bergmeier et al.
patent: 4837241 (1989-06-01), Jensen et al.
patent: 4866077 (1989-09-01), Bogeso et al.
patent: 4925858 (1990-05-01), Bogeso et al.
patent: 4927837 (1990-05-01), Galliani et al.
patent: 4933353 (1990-06-01), Jensen et al.
patent: 4937239 (1990-06-01), Lauffer et al.
patent: 4968691 (1990-11-01), Orlek et al.
Tamura et al., Chemical Abstracts, vol. 84, No. 175159v (1976).
Wells et al., Chemical Abstracts, vol. 67, No. 99958m (1967).
Baker et al., Chemical Abstracts, vol. 109, No. 54780s (1988).
Beecham Group PLC, Chemical Abstracts, vol. 110, No. 115165q (1989).
Bergmeier et al., Chemical Abstracts, vol. 110, No. 57518u (1989).
Bogeso et al., Chemical Abstracts, vol. 110, No. 192831f (1989).
Galliani et al., Chemical Abstracts, vol. 108, No. 204502y (1988).
Mastafanova et al., Chemical Abstracts, vol. 64, No. 12642f (1966).
Saunders et al., Chemical Abstracts, vol. 111, No. 39157s (1989).
Kindtler Jens W.
Nielson Lone
Olesen Preben H.
Sauerberg Per
Watjen Frank
Lambiris Elias J.
Lee Mary C.
Novo Nordisk A S
Powers Fiona T.
Zelson Steve T.
LandOfFree
3-substituted and optionally 1-substituted azacyclic or azabicyc does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-substituted and optionally 1-substituted azacyclic or azabicyc, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-substituted and optionally 1-substituted azacyclic or azabicyc will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-22844